Freenome

About:

Freenome is a biotechnology company with a comprehensive multiomics platform for cancer detection using a routine blood draw.

Website: https://www.freenome.com

Twitter/X: freenome

Top Investors: Verily, RA Capital Management, Novartis, Andreessen Horowitz, Fidelity

Description:

Freenome is a biotech company developing accurate, accessible, and non-invasive disease screening products for proactively treating cancer and other diseases at their most manageable stages. The company is developing a simple blood test to detect early-stage cancer and make treatments more effective and provides a platform that helps design healthy conditions for an individual based on his/her cell-free genome. The company aims to reinvent disease management through systematized early detection and intervention.